The first refractive laser systems approved by FDA were excimer lasers for use in PRK to treat myopia and later to treat astigmatism, for use in laser refractive surgery. Over the last several years, LASIK has become the main laser refractive surgery used to treat myopia. Conventional LASIK (Laser Assisted In Situ Keratomileusis) can correct short sight, long sight and astigmatism, accounting for around 95 per cent of refractive error.
Keratoconus is sometimes detected during screening for Lasik surgery. The first part of Lasik consultation includes taking a corneal map of the eye, which reveals the degree of keratoconus, if any. In this case, for patients discovered to have keratonconus, laser refractive surgery such as Lasik is no longer an option. However, if the keratoconus is able to be first successfully treated with Mini ARK, then the patient may qualify for a later, post keratoconus Lasik or PRK intervention.
Dr. Lombardi made a breakthrough in the treatment of keratoconus in the early 80s, when he applied the same principles used in Radial Keratotomy, strategically located incisions in the cornea to correct myopia disorders, to treat keratoconus with his Mini ARK.
To read a first-hand report on how in a patient with keratoconus, lasik surgery was successfully performed by Dr. Lombardi with Mini Ark Surgery, consult Testimony of Mini ARK Surgery 2004 - 2005 by Jimmy Peacock.